MIS MiLIF Versus Open

Sponsor
Zimmer Biomet (Industry)
Overall Status
Completed
CT.gov ID
NCT00792129
Collaborator
(none)
113
9
62
12.6
0.2

Study Details

Study Description

Brief Summary

This study is being undertaken to compare the clinical outcomes of patients that have unilateral posterolateral lumbar interbody fusion using a traditional open approach versus the MiLIF procedure based on the MiCOR Precision Bone Allograft, specialized Atavi instrumentation, and minimally invasive visualization capabilities.

Condition or Disease Intervention/Treatment Phase
  • Device: The Atavi System

Detailed Description

This is a prospective, multi-center, non-randomized cohort design clinical study to evaluate the clinical outcomes of patients that have a minimally invasive lumbar interbody fusion (MiLIF) through the Atavi system compared to traditional unilateral open lumbar interbody fusion through a midline incision. the study will involve up to approximately 12 investigational sites and enroll up to 126 patients.

Study Design

Study Type:
Observational
Actual Enrollment :
113 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
A Multi-Center Study to Evaluate MiLIF(R) Versus Open Posterior Unilateral Lumbar Interbody Fusion (TLIF)
Study Start Date :
Apr 1, 2004
Actual Primary Completion Date :
Mar 1, 2006
Actual Study Completion Date :
Jun 1, 2009

Arms and Interventions

Arm Intervention/Treatment
Control

Posterior unilateral interbody fusion using an open approach midline incision (TLIF)

Device: The Atavi System
The primary device in the Atavi system is the Flex Posture retractor and accessories such as dilators and an Expander Instrument. The Atavi System includes instruments used to access the spine by dilation of the overlying tissues, as well as a retracting device that is used to maintain the access. Once the retractor is in place, the visualization components of the system may be used.
Other Names:
  • MIS
  • Minimally invasive
  • Atavi
  • Flex Posure
  • retractor
  • Experimental

    MiLIF procedure with specialized Atavi instrumentation and minimally invasive visualization capabilities

    Device: The Atavi System
    The primary device in the Atavi system is the Flex Posture retractor and accessories such as dilators and an Expander Instrument. The Atavi System includes instruments used to access the spine by dilation of the overlying tissues, as well as a retracting device that is used to maintain the access. Once the retractor is in place, the visualization components of the system may be used.
    Other Names:
  • MIS
  • Minimally invasive
  • Atavi
  • Flex Posure
  • retractor
  • Outcome Measures

    Primary Outcome Measures

    1. Clinical Outcomes [MiLIF and Open groups at 3 months post-procedure as defined by the mean Oswestry score]

    Secondary Outcome Measures

    1. Clinical Outcomes [The percent of patients that have a successful fusion at one year post-procedure as measured by radiographs]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 75 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patient is between 18 and 75 years of age

    • Patient is scheduled for an elective spinal lumbar interbody single level fusion

    • Patient is a candidate for posterior unilateral lumbar fusion through a midline incision

    • Indication for surgery and dominant symptom of chronic low back and/or leg pain

    • Diagnosis of one or more of the following:

    • Primary symptomatic degenerative disc disease confirmed with appropriate imaging studies and/or positive lumbar discography

    • Spondylolisthesis Grade I/II

    • The affected motion segment reside in L2-S1 and are adjacent segments

    • Patient, or authorized representative, signs a written Informed Consent form to participate in the study, prior to any study mandated determinations or procedure.

    Exclusion Criteria:
    • Patient has a known fracture in the lumbar spine

    • Patient has systemic infection or evidence of any surgical site infection (superficial or organ space)

    • Patient has compromised immune system or autoimmune disease (WBC<4000 or >20,000)

    • Patient has uncontrolled diabetes

    • Patient has a known malignancy

    • Prior lumbar fusion attempt; prior laminectomy and/or discectomy are allowed

    • Known medical or anatomical condition that would preclude a posterior lumbar fusion using metallic instrumentation (e.g., severe osteopenia)

    • Patient with a planned placement of an electric bone stimulator

    • Patient with a planned placement of indwelling epidural catheter for a long term pain management

    • Patient is pregnant or wishes to become pregnant during the length of the study participation

    • Patient is currently in litigation

    • Patient is not likely to comply with the follow-up evaluation schedule

    • Patient is participating in a clinical trial of another investigational drug or device.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 La Jolla Spine Institute La Jolla California United States 92037
    2 Sharp Rees-Stealy Medical Group San Diego California United States 92123
    3 Advanced Orthopedic Center Port Charlotte Florida United States 33948
    4 Southeastern Spine Center Sarasota Florida United States 34232
    5 Kennedy-White Orthopedic Sarasota Florida United States 34233
    6 Oregon Brain & Spinal Institute Portland Oregon United States 97225
    7 Williamette Neurosurgery Salem Oregon United States 97302
    8 William Beaumont Army Medical Center El Paso Texas United States 97720-5001
    9 Naval Medical Center Portsmouth Virginia United States 23708

    Sponsors and Collaborators

    • Zimmer Biomet

    Investigators

    • Study Director: Joe Murar, M.D., Zimmer Spine

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Zimmer Biomet
    ClinicalTrials.gov Identifier:
    NCT00792129
    Other Study ID Numbers:
    • ATV-03-002
    • 2007-003
    First Posted:
    Nov 17, 2008
    Last Update Posted:
    Feb 16, 2012
    Last Verified:
    Feb 1, 2012

    Study Results

    No Results Posted as of Feb 16, 2012